N/A
Completed N=77
Efficacy of Movement Breaks in Real-World Settings
Healthy
Source: ClinicalTrials.gov NCT05574426 ↗
Enrolled (actual)
77
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcomePrimary: Change From Baseline in Cardiorespiratory Fitness at 12 Weeks — -0.6; -1.0 ml/kg/min
Summary
The purpose of this study is to determine the efficacy of performing "exercise snacks" (short movement breaks throughout the day) on various measures of cardiometabolic health.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Cardiorespiratory Fitness at 12 Weeks |
-0.6; -1.0 | — |
| SECONDARY Change From Baseline in Plasma Insulin |
-13; -2 | — |
| SECONDARY Change From Baseline in Plasma Glucose |
— | — |
| SECONDARY Change From Baseline in Insulin Resistance |
— | — |
| SECONDARY Change From Baseline in Inflammatory Cytokines |
— | — |
| SECONDARY Change From Baseline in Body Mass |
— | — |
| SECONDARY Change From Baseline in Waist Circumference |
— | — |
| SECONDARY Device-Measured Adherence to Movement Breaks |
— | — |
| SECONDARY Self-Reported Adherence to Movement Breaks |
— | — |
| SECONDARY Movement Break Enjoyment Assessed by the Exercise Enjoyment Scale (EES) |
— | — |
| SECONDARY Rating of Perceived Exertion (RPE) Following Movement Breaks |
— | — |
Eligibility Criteria
Inclusion Criteria
- Physically inactive (performing <150 minutes of moderate-to-vigorous intensity aerobic exercise per week, assessed by pre-screening Get Active Questionnaire);
- Body Mass Index: 18.5-30.0 kg/m2;
- Not currently diagnosed with or being treated for cardiometabolic disease (e.g., coronary artery disease, diabetes);
- Not a current smoker;
- Cleared to engage in physical activity using the Get Active Questionnaire and, if applicable, consultation with a Qualified Exercise Professional;
- Access to a computer, tablet or smartphone for intervention delivery and tracking
Exclusion Criteria
- Chronic health condition preventing participation in exercise;
- Lack of access to internet connection
Data sourced from ClinicalTrials.gov (NCT05574426). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.